Although effective at reducing hyperglycemia, metformin has not been proven to prevent the conversion from impaired glucose tolerance to frank T2DM, only slowing the progression of disease while maintaining the rate of beta cell function deterioration when compared to other treatment options such as sulfonylureas or insulin injections (7). Here, INS is linked to type 2 diabetes mellitus.